The dark side of the ‘miracle jab’: why eating disorder safety cannot be an afterthought In recent years, glucagon-like peptide-1 receptor agonists (GLP-1s), such as Ozempic (semaglutide; Novo Nordisk), Wegovy (semaglutide; Novo Nordisk) and Mounjaro (tirzepatide; Eli Lilly) have been…

In this blog piece #ChetanShah and #AnastaciaTew highlight that as the use of glucagon-like peptide-1 receptor agonists increases, so must our awareness of patients who have an eating disorder or who are at risk of developing one

#ukpharmacy #eatingdisorder #weightlossinjections